Radioprotective effect of ginseng in thyroid cancer patients
Phase 3
Completed
- Conditions
- thyroid cancer.Malignant neoplasm of thyroid gland
- Registration Number
- IRCT20200115046136N1
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Patients between the ages of 30 and 60 who had thyroid cancer and underwent thyroid surgery.
Patients who first receive radioactive iodine.
Exclusion Criteria
People who have undergone radiotherapy or chemotherapy in the last year.
People with certain genetic diseases.
People taking medications for heart and kidney failure, and those who take Warfarin anticoagulants definitively.
People who smoke.
People who are radiant
People who have taken ginseng in the last month.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method